{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:07:57Z","timestamp":1788815277239,"version":"build-2803163510"},"reference-count":300,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32460174"],"award-info":[{"award-number":["32460174"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20242BAB26152"],"award-info":[{"award-number":["20242BAB26152"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20232BAB206096"],"award-info":[{"award-number":["20232BAB206096"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004637","name":"Nanchang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118338","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T23:27:08Z","timestamp":1786145228000},"page":"118338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["PD-1+\/PD-L1+macrophages across diseases: a translational continuum from biomarkers to immunotherapeutic targets"],"prefix":"10.1016","volume":"253","author":[{"given":"Jinjing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunpeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenkui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianyu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1227-2436","authenticated-orcid":false,"given":"Daya","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118338_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2019.09.030","article-title":"Mechanisms controlling PD-L1 expression in cancer","author":"Cha","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2026.118338_b0010","article-title":"Identification and characterization of the amphioxus lck and its associated tyrosine phosphorylation-dependent inhibitory LRR receptor","author":"Zhou","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0015","doi-asserted-by":"crossref","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","author":"Freeman","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2026.118338_b0020","doi-asserted-by":"crossref","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0025","article-title":"The role of PD-1\/PD-L1 and application of immune-checkpoint inhibitors in human cancers","author":"Tang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0030","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-022-00854-y","article-title":"Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons","author":"Naimi","year":"2022","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bcp.2026.118338_b0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41590-021-01125-7","article-title":"PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity","author":"Sugiura","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00487","article-title":"The role of PD-1 in acute and chronic infection","author":"Jubel","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-08352-5","article-title":"PD-1\/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model","author":"Rosenzweig","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118338_b0050","doi-asserted-by":"crossref","unstructured":"Lazarov T, Juarez-Carre\u00f1o S, Cox N, Geissmann F. Physiology and diseases of tissue-resident macrophages [published correction appears in Nature. 2023; doi:10.1038\/s41586-023-06002-x.","DOI":"10.1038\/s41586-023-06386-w"},{"key":"10.1016\/j.bcp.2026.118338_b0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.118338_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112090","article-title":"Periostin deficiency reduces PD-1+ tumor-associated macrophage infiltration and enhances anti-PD-1 efficacy in colorectal cancer","author":"Wei","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2026.118338_b0065","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-022-03187-4","article-title":"The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma","author":"Shinchi","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bcp.2026.118338_b0070","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0864-3","article-title":"Biomarkers for predicting efficacy of PD-1\/PD-L1 inhibitors","author":"Yi","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.118338_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2019.06.008","article-title":"Removal of N-linked glycosylation enhances PD-L1 detection and predicts anti-PD-1\/PD-L1 therapeutic efficacy","author":"Lee","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2026.118338_b0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-022-01136-2","article-title":"Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.118338_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.33142","article-title":"Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non-small cell lung cancer without tumor PD-L1 expression: A pooled analysis of 3 randomized controlled trials","author":"Borghaei","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2026.118338_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2024.04.011","article-title":"Pembrolizumab plus chemotherapy for metastatic NSCLC with programmed cell death ligand 1 tumor proportion score less than 1%: pooled analysis of outcomes after five years of follow-up","author":"Gadgeel","year":"2024","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bcp.2026.118338_b0095","article-title":"Multiplexed immunofluorescence identifies high stromal CD68+PD-L1+ macrophages as a predictor of improved survival in triple negative breast cancer","author":"Wang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118338_b0100","article-title":"Short-term starvation boosts anti-PD-L1 therapy by reshaping tumor-associated macrophages in hepatocellular carcinoma","author":"Cheng","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2026.118338_b0105","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aay1863","article-title":"Targeted deletion of PD-1 in myeloid cells induces antitumor immunity","author":"Strauss","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0110","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","author":"Lin","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.118338_b0115","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd2712","article-title":"Revisiting the PD-1 pathway","author":"Patsoukis","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bcp.2026.118338_b0120","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-15-0244","article-title":"Differential expression of immune-regulatory genes associated with PD-L1 display in melanoma: implications for PD-1 pathway blockade","author":"Taube","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118338_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00491","article-title":"Macrophage cytokines: involvement in immunity and infectious diseases","author":"Arango Duque","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0130","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201932RR","article-title":"Heterogeneity of macrophages in atherosclerosis revealed by single-cell RNA sequencing","author":"Yu","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2026.118338_b0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-49885-8","article-title":"Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response","author":"Coulton","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118338_b0140","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-23-1300","article-title":"Spatially segregated macrophage populations predict distinct outcomes in colon cancer","author":"Matusiak","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bcp.2026.118338_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.it.2023.10.007","article-title":"Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies","author":"Nasir","year":"2023","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0150","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.181.7.4832","article-title":"NFATc1 regulates PD-1 expression upon T cell activation","author":"Oestreich","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0155","article-title":"PD-1+ CD4 T cell immune response is mediated by HIF-1\u03b1\/NFATc1 pathway after P. yoelii infection","author":"Wei","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0160","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-17-3297","article-title":"NFATc1 promotes antitumoral effector functions and memory CD8+ T-cell differentiation during non-small cell lung cancer development","author":"Heim","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118338_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2008.08.003","article-title":"Interferon-sensitive response element (ISRE) is mainly responsible for IFN-alpha-induced upregulation of programmed death-1 (PD-1) in macrophages","author":"Cho","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2026.118338_b0170","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1402550","article-title":"NF-\u03baB regulates PD-1 expression in macrophages","author":"Bally","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0175","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2017.12","article-title":"The role of PD-1 in regulation of macrophage apoptosis and its subversion by Leishmania donovani","author":"Roy","year":"2017","journal-title":"Clin Transl Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0180","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-20-3510","article-title":"A MyD88\/IL1R axis regulates PD-1 expression on tumor-associated macrophages and sustains their immunosuppressive function in melanoma","author":"Tartey","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118338_b0185","doi-asserted-by":"crossref","DOI":"10.1158\/1541-7786.MCR-21-0786","article-title":"Diurnal expression of PD-1 on tumor-associated macrophages underlies the dosing time-dependent antitumor effects of the PD-1\/PD-L1 inhibitor BMS-1 in B16\/BL6 melanoma-bearing mice","author":"Tsuruta","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118338_b0190","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165544","article-title":"TGF-\u03b21 induces PD-1 expression in macrophages through SMAD3\/STAT3 cooperative signaling in chronic inflammation","author":"Lei","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.bcp.2026.118338_b0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-024-07529-3","article-title":"Obesity induces PD-1 on macrophages to suppress anti-tumour immunity","author":"Bader","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118338_b0200","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.02686-14","article-title":"Myeloid-derived suppressor cells impair alveolar macrophages through PD-1 receptor ligation during Pneumocystis pneumonia","author":"Lei","year":"2015","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bcp.2026.118338_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2022.06.001","article-title":"Macrophage PD-1 associates with neutrophilia and reduced bacterial killing in early cystic fibrosis airway disease","author":"Margaroli","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.bcp.2026.118338_b0210","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-16-3215","article-title":"PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression","author":"Jiao","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118338_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01337","article-title":"Recent findings in the regulation of programmed death ligand 1 expression","author":"Shen","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0220","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-020-01027-5","article-title":"Regulation of PD-L1 expression in the tumor microenvironment","author":"Yi","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2026.118338_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104181","article-title":"Expression, regulation, and function of PD-L1 on non-tumor cells in the tumor microenvironment","author":"Hu","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bcp.2026.118338_b0230","doi-asserted-by":"crossref","DOI":"10.1172\/JCI137110","article-title":"Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma","author":"Loeuillard","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118338_b0235","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2021-326350","article-title":"PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma","author":"Lu","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2026.118338_b0240","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2018020602","article-title":"PD-L1 and tumor-associated macrophages in de novo DLBCL","author":"McCord","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.bcp.2026.118338_b0245","doi-asserted-by":"crossref","DOI":"10.1186\/s43556-023-00151-1","article-title":"JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions","author":"Sarapultsev","year":"2023","journal-title":"Mol Biomed."},{"key":"10.1016\/j.bcp.2026.118338_b0250","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0931259100","article-title":"PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells","author":"Loke","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2026.118338_b0255","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000285","article-title":"IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma","author":"Zhang","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bcp.2026.118338_b0260","doi-asserted-by":"crossref","DOI":"10.1002\/cbin.10716","article-title":"Bladder cancer cells induce immunosuppression of T cells by supporting PD-L1 expression in tumour macrophages partially through interleukin 10","author":"Wang","year":"2017","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bcp.2026.118338_b0265","doi-asserted-by":"crossref","DOI":"10.1111\/cas.13065","article-title":"An IL-27\/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1\/2) on infiltrating macrophages in lymphoma","author":"Horlad","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bcp.2026.118338_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106012","article-title":"Breast cancer cells promote CD169+ macrophage-associated immunosuppression through JAK2-mediated PD-L1 upregulation on macrophages","author":"Jing","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2026.118338_b0275","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-020-01786-6","article-title":"Progranulin induces immune escape in breast cancer via upregulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8+ T cell exclusion","author":"Fang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118338_b0280","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16080-y","article-title":"GM-CSF derived from the inflammatory microenvironment potentially enhanced PD-L1 expression on tumor-associated macrophages in human breast cancer","author":"Yonemitsu","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118338_b0285","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-20-3471","article-title":"\u03b11-Acid glycoprotein enhances the immunosuppressive and protumor functions of tumor-associated macrophages","author":"Matsusaka","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118338_b0290","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2269790","article-title":"AIM2 fosters lung adenocarcinoma immune escape by modulating PD-L1 expression in tumor-associated macrophages via JAK\/STAT3","author":"Ye","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.bcp.2026.118338_b0295","doi-asserted-by":"crossref","DOI":"10.1002\/cac2.12420","article-title":"High baseline tumor burden-associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2-STAT3-PD-L1 pathway","author":"Wen","year":"2023","journal-title":"Cancer Commun (Lond)."},{"key":"10.1016\/j.bcp.2026.118338_b0300","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146707","article-title":"Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function","author":"Petty","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.bcp.2026.118338_b0305","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.2024941","article-title":"MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression","author":"Lin","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bcp.2026.118338_b0310","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-018-0452-5","article-title":"Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1","author":"Wen","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bcp.2026.118338_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2025.114519","article-title":"CMTM4 promotes PD-L1-mediated macrophage apoptosis by enhancing STAT2 phosphorylation in sepsis","author":"Qi","year":"2025","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2026.118338_b0320","doi-asserted-by":"crossref","DOI":"10.1111\/imm.13602","article-title":"Ataxia telangiectasia mutated kinase inhibition promotes irradiation-induced PD-L1 expression in tumour-associated macrophages through IFN-I\/JAK signalling pathway","author":"Gao","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.bcp.2026.118338_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113651","article-title":"Increased OIT3 in macrophages promotes PD-L1 expression and hepatocellular carcinogenesis via NF-\u03baB signaling","author":"Wen","year":"2023","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2026.118338_b0330","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1819473116","article-title":"Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1","author":"Roux","year":"2019","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2026.118338_b0335","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2300846","article-title":"Gut microbiome-derived butyrate inhibits the immunosuppressive factors PD-L1 and IL-10 in tumor-associated macrophages in gastric cancer","author":"Lee","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bcp.2026.118338_b0340","article-title":"Polyphyllin I ameliorates gefitinib resistance and inhibits the VEGF\/VEGFR2\/p38 pathway by targeting HIF-1a in lung adenocarcinoma","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.118338_b0345","article-title":"ABCF1-K430-Lactylation promotes HCC malignant progression via transcriptional activation of HIF1 signaling pathway","author":"Hong","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2026.118338_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110652","article-title":"Intermittent hypoxia inhibits anti-tumor immune response via regulating PD-L1 expression in lung cancer cells and tumor-associated macrophages","author":"Cui","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2026.118338_b0355","doi-asserted-by":"crossref","DOI":"10.1038\/s41417-022-00551-5","article-title":"HIF-1\u03b1\/IL-8 axis in hypoxic macrophages promotes esophageal cancer progression by enhancing PD-L1 expression","author":"Song","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bcp.2026.118338_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117585","article-title":"Physiological and tumor-associated angiogenesis: Key factors and therapy targeting VEGF\/VEGFR pathway","author":"Lorenc","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.118338_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112655","article-title":"YAP\/STAT3 promotes the immune escape of larynx carcinoma by activating VEGFR1-TGF\u03b2 signaling to facilitate PD-L1 expression in M2-like TAMs","author":"Du","year":"2021","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2026.118338_b0370","article-title":"Interaction between PD-L1 and soluble VEGFR1 in glioblastoma-educated macrophages","author":"Liu","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2026.118338_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2022.10.010","article-title":"Cancer cell-intrinsic XBP1 drives immunosuppressive reprogramming of intratumoral myeloid cells by promoting cholesterol production","author":"Yang","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2026.118338_b0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000687","article-title":"IRE1\u03b1 regulates macrophage polarization, PD-L1 expression, and tumor survival","author":"Batista","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bcp.2026.118338_b0385","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-020-0872-0","article-title":"KSHV infection skews macrophage polarisation towards M2-like\/TAM and activates Ire1 \u03b1-XBP1 axis up-regulating pro-tumorigenic cytokine release and PD-L1 expression","author":"Gilardini Montani","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2026.118338_b0390","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-020-00306-0","article-title":"RNA in cancer","author":"Goodall","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2026.118338_b0395","doi-asserted-by":"crossref","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of microRNA biogenesis, function and decay","author":"Krol","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bcp.2026.118338_b0400","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-021-00810-2","article-title":"Endoplasmic reticulum stress promotes the release of exosomal PD-L1 from head and neck cancer cells and facilitates M2 macrophage polarization","author":"Yuan","year":"2022","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bcp.2026.118338_b0405","doi-asserted-by":"crossref","DOI":"10.7150\/ijbs.19642","article-title":"Exosomes from melatonin treated hepatocellularcarcinoma cells alter the immunosupression status through STAT3 pathway in macrophages","author":"Cheng","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bcp.2026.118338_b0410","article-title":"Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM\/PD-L1 signaling","author":"Wang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118338_b0415","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1412909","article-title":"Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes","author":"Gabrusiewicz","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bcp.2026.118338_b0420","article-title":"Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p\/PD-L1 pathway","author":"Li","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118338_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2017.11.058","article-title":"MiR-142 inhibits cecal ligation and puncture (CLP)-induced inflammation via inhibiting PD-L1 expression in macrophages and improves survival in septic mice","author":"Zhen","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.118338_b0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113261","article-title":"Colorectal cancer cell-derived exosomal miRNA-372-5p induces immune escape from colorectal cancer via PTEN\/AKT\/NF-\u03baB\/PD-L1 pathway","author":"Wu","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2026.118338_b0435","article-title":"Endoplasmic reticulum stress causes liver cancer cells to release exosomal miR-23a-3p and up-regulate programmed death ligand 1 expression in macrophages","author":"Liu","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2026.118338_b0440","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.30390","article-title":"Gastric cancer-derived exosomes facilitate pulmonary metastasis by activating ERK-mediated immunosuppressive macrophage polarization","author":"Gu","year":"2023","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcp.2026.118338_b0445","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.15367","article-title":"Endoplasmic reticulum stress-induced exosomal miR-27a-3p promotes immune escape in breast cancer via regulating PD-L1 expression in macrophages","author":"Yao","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bcp.2026.118338_b0450","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-023-02980-0","article-title":"Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages","author":"Xu","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bcp.2026.118338_b0455","article-title":"Colorectal cancer-derived small extracellular vesicles promote tumor immune evasion by upregulating PD-L1 expression in tumor-associated macrophages","author":"Yin","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.bcp.2026.118338_b0460","doi-asserted-by":"crossref","DOI":"10.1007\/s13402-023-00839-0","article-title":"Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer","author":"He","year":"2023","journal-title":"Cell. Oncol. (Dordr.)"},{"key":"10.1016\/j.bcp.2026.118338_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110868","article-title":"Exosomal circRNA-001264 promotes AML immunosuppression through induction of M2-like macrophages and PD-L1 overexpression","author":"Du","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2026.118338_b0470","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2016.328","article-title":"PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia","author":"Goltz","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2026.118338_b0475","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2267744","article-title":"PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma","author":"Kl\u00fcmper","year":"2023","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bcp.2026.118338_b0480","article-title":"Analysis of PD-L1 promoter methylation combined with immunogenic context in pancreatic ductal adenocarcinoma","author":"Chen","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bcp.2026.118338_b0485","article-title":"PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients","author":"Goltz","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bcp.2026.118338_b0490","doi-asserted-by":"crossref","DOI":"10.15698\/mic2024.07.832","article-title":"Promoter methylation and increased expression of PD-L1 in patients with active tuberculosis","author":"Tseng","year":"2024","journal-title":"Microb. Cell"},{"key":"10.1016\/j.bcp.2026.118338_b0495","article-title":"PRMT5 deficiency in myeloid cells reprograms macrophages to enhance antitumor immunity and synergizes with anti-PD-L1 therapy","author":"Chen","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bcp.2026.118338_b0500","article-title":"Proinflammatory S100A8 induces PD-L1 expression in macrophages, mediating tumor immune escape","author":"Li","year":"2020","journal-title":"J Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0505","article-title":"PD-L1 methylation restricts PD-L1\/PD-1 interactions to control cancer immune surveillance","author":"Huang","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bcp.2026.118338_b0510","article-title":"PD-L1 promoter methylation mediates the resistance response to anti-PD-1 therapy in NSCLC patients with EGFR-TKI resistance","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2026.118338_b0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2016.10.010","article-title":"Deubiquitination and stabilization of PD-L1 by CSN5","author":"Lim","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2026.118338_b0520","doi-asserted-by":"crossref","DOI":"10.1002\/mc.23176","article-title":"EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma","author":"Su","year":"2020","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bcp.2026.118338_b0525","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-017-1955-5","article-title":"Regulation of PD-L1 expression on murine tumor-associated monocytes and macrophages by locally produced TNF-\u03b1","author":"Hartley","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bcp.2026.118338_b0530","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200434RR","article-title":"TNF-\u03b1-dependent lung inflammation upregulates PD-L1 in monocyte-derived macrophages to contribute to lung tumorigenesis","author":"Wen","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2026.118338_b0535","doi-asserted-by":"crossref","DOI":"10.1038\/s43018-025-00909-2","article-title":"Linking macrophage metabolism to function in the tumor microenvironment","author":"Jin","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bcp.2026.118338_b0540","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.118338_b0545","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1612920114","article-title":"COX2\/mPGES1\/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells","author":"Prima","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2026.118338_b0550","doi-asserted-by":"crossref","DOI":"10.2174\/1574888X17666220127110332","article-title":"Human umbilical cord mesenchymal stem cells promote macrophage PD-L1 expression and attenuate acute lung injury in mice","author":"Tu","year":"2022","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.bcp.2026.118338_b0555","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009492","article-title":"ALOX5 contributes to glioma progression by promoting 5-HETE-mediated immunosuppressive M2 polarization and PD-L1 expression of glioma-associated microglia\/macrophages","author":"Chen","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bcp.2026.118338_b0560","doi-asserted-by":"crossref","DOI":"10.7150\/ijbs.74456","article-title":"4-Octyl itaconate regulates immune balance by activating Nrf2 and negatively regulating PD-L1 in a mouse model of sepsis","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bcp.2026.118338_b0565","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01300","article-title":"Pyruvate kinase M2 Is required for the expression of the immune checkpoint PD-L1 in immune cells and tumors","author":"Palsson-McDermott","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110401","article-title":"Shikonin inhibits immune checkpoint PD-L1 expression on macrophage in sepsis by modulating PKM2","author":"Yuan","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2026.118338_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2018.06.026","article-title":"The circadian clock controls immune checkpoint pathway in sepsis","author":"Deng","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2026.118338_b0580","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2057837","article-title":"Myeloma-derived IL-32\u03b3 induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis","author":"Liu","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bcp.2026.118338_b0585","doi-asserted-by":"crossref","DOI":"10.1172\/JCI92167","article-title":"Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity","author":"Watanabe","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118338_b0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2021.09.002","article-title":"Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming","author":"Morrissey","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2026.118338_b0595","doi-asserted-by":"crossref","DOI":"10.3892\/or.2020.7767","article-title":"M2-TAM subsets altered by lactic acid promote T-cell apoptosis through the PD-L1\/PD-1 pathway","author":"Shan","year":"2020","journal-title":"Oncol. Rep."},{"issue":"20","key":"10.1016\/j.bcp.2026.118338_b0600","article-title":"Lactylation-driven NUPR1 promotes immunosuppression of tumor-infiltrating macrophages in hepatocellular carcinoma","volume":"12","author":"Cai","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"issue":"33","key":"10.1016\/j.bcp.2026.118338_b0605","article-title":"NDRG1-driven lactate accumulation promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment","volume":"12","author":"Wu","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.bcp.2026.118338_b0610","article-title":"Blockade of purine metabolism reverses macrophage immunosuppression and enhances anti-tumor immunity in non-small cell lung cancer","author":"Yang","year":"2025","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bcp.2026.118338_b0615","doi-asserted-by":"crossref","DOI":"10.3727\/096368916X692096","article-title":"Physiologic doses of bilirubin contribute to tolerance of islet transplants by suppressing the innate immune response","author":"Adin","year":"2017","journal-title":"Cell Transplant."},{"key":"10.1016\/j.bcp.2026.118338_b0620","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-024-01134-0","article-title":"Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through \u03b1-ketoglutarate and mTORC1 signaling","author":"Cai","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0625","article-title":"ZNT1 and Zn 2+ control TLR4 and PD-L1 endocytosis in macrophages to improve chemotherapy efficacy against liver tumor","author":"Yang","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2026.118338_b0630","article-title":"Targeted xCT-mediated ferroptosis and protumoral polarization of macrophages is effective against HCC and enhances the efficacy of the anti-PD-1\/L1 response","author":"Tang","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.bcp.2026.118338_b0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.09.007","article-title":"Immune checkpoint inhibition overcomes ADCP-induced immunosuppression by macrophages","author":"Su","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118338_b0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2017.08.028","article-title":"Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma","author":"Zhang","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2026.118338_b0645","doi-asserted-by":"crossref","DOI":"10.1007\/s13402-021-00594-0","article-title":"Role of TGF-\u03b2 in pancreatic ductal adenocarcinoma progression and PD-L1 expression","author":"Hussain","year":"2021","journal-title":"Cell. Oncol. (Dordr.)"},{"key":"10.1016\/j.bcp.2026.118338_b0650","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2018-316324","article-title":"Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer","author":"Lin","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2026.118338_b0655","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-018-0049-3","article-title":"Tumor-derived exosomes induce PD1+ macrophage population in human gastric cancer that promotes disease progression","author":"Wang","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bcp.2026.118338_b0660","article-title":"PD-1\/PD-L1 blockade is a potent adjuvant in treatment of Staphylococcus aureus osteomyelitis in mice","author":"Li","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bcp.2026.118338_b0665","article-title":"Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity","author":"Zhong","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2026.118338_b0670","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2338951","article-title":"PD-L1+ macrophages suppress T cell-mediated anticancer immunity","author":"Liu","year":"2024","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.bcp.2026.118338_b0675","doi-asserted-by":"crossref","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","author":"Gordon","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118338_b0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytogfr.2022.07.004","article-title":"Correlation between PD-1\/PD-L1 expression and polarization in tumor-associated macrophages: A key player in tumor immunotherapy","author":"Li","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bcp.2026.118338_b0685","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-013-0254-x","article-title":"Programmed death 1 deficiency induces the polarization of macrophages\/microglia to the M1 phenotype after spinal cord injury in mice","author":"Yao","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bcp.2026.118338_b0690","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.33","article-title":"Attenuation of the programmed cell death-1 pathway increases the M1 polarization of macrophages induced by zymosan","author":"Chen","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.118338_b0695","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-022-02758-x","article-title":"Programmed death-1 deficiency aggravates motor dysfunction in MPTP model of parkinson's disease by inducing microglial activation and neuroinflammation in mice","author":"Cheng","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2026.118338_b0700","article-title":"Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes\/macrophages in hepatitis C virus infection","author":"Zhang","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0705","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2567.2010.03382.x","article-title":"PD-1 negatively regulates interleukin-12 expression by limiting STAT-1 phosphorylation in monocytes\/macrophages during chronic hepatitis C virus infection","author":"Ma","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.bcp.2026.118338_b0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2009.08.011","article-title":"Programmed death-1 receptor negatively regulates LPS-mediated IL-12 production and differentiation of murine macrophage RAW264.7 cells","author":"Cho","year":"2009","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bcp.2026.118338_b0715","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-025-06469-4","article-title":"PD-1 regulates the anti-tumor immune function of macrophages through JAK2-STAT3 signaling pathway in colorectal cancer tumor microenvironment","author":"Jiang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2026.118338_b0720","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-020-02499-0","article-title":"The effect of PD-1 expression on tumor-associated macrophage in T cell lymphoma","author":"Ruan","year":"2021","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.bcp.2026.118338_b0725","doi-asserted-by":"crossref","DOI":"10.1002\/JLB.1A0420-012RR","article-title":"Trophoblast-secreted soluble-PD-L1 modulates macrophage polarization and function","author":"Zhang","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2026.118338_b0730","doi-asserted-by":"crossref","DOI":"10.1093\/humrep\/dey347","article-title":"The role of the PD-1\/PD-L1 axis in macrophage differentiation and function during pregnancy","author":"Zhang","year":"2019","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.bcp.2026.118338_b0735","article-title":"A newly intervention strategy in preeclampsia: Targeting PD-1\/Tim-3 signaling pathways to modulate the polarization of decidual macrophages","author":"Hu","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2026.118338_b0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2021.03.013","article-title":"Inhibition of xCT suppresses the efficacy of anti-PD-1\/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization","author":"Liu","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bcp.2026.118338_b0745","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-020-02741-2","article-title":"OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1\/2 signaling pathway","author":"Pang","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bcp.2026.118338_b0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112575","article-title":"PD-L1 induces macrophage polarization toward the M2 phenotype via Erk\/Akt\/mTOR","author":"Wei","year":"2021","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2026.118338_b0755","doi-asserted-by":"crossref","DOI":"10.1158\/2326-6066.CIR-17-0537","article-title":"Programmed cell death ligand 1 (PD-L1) signaling regulates macrophage proliferation and activation","author":"Hartley","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bcp.2026.118338_b0760","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.17610","article-title":"PD-L1\/p-STAT3 promotes the progression of NSCLC cells by regulating TAM polarization","author":"Zhang","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bcp.2026.118338_b0765","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2022.5440","article-title":"PD-L1 mediates triple-negative breast cancer evolution via the regulation of TAM\/M2 polarization","author":"Meng","year":"2022","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bcp.2026.118338_b0770","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1510179","article-title":"PD-L1 knockout or ZG16 overexpression inhibits PDAC progression and modulates TAM polarization","author":"Meng","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0775","article-title":"PD-L1-expressing tumor-associated macrophages are immunostimulatory and associate with good clinical outcome in human breast cancer","author":"Wang","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"10","key":"10.1016\/j.bcp.2026.118338_b0780","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1158\/1078-0432.CCR-22-3350","article-title":"Reversal of lactate and PD-1-mediated macrophage immunosuppression controls growth of PTEN\/p53-deficient prostate cancer","volume":"29","author":"Chaudagar","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118338_b0785","article-title":"Expression of PD-1 mitigates phagocytic activities TAM in osteosarcoma","author":"Zheng","year":"2023","journal-title":"Heliyon."},{"key":"10.1016\/j.bcp.2026.118338_b0790","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2016.214","article-title":"The PD-1\/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia","author":"Qorraj","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2026.118338_b0795","article-title":"PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis","author":"Huang","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2026.118338_b0800","doi-asserted-by":"crossref","DOI":"10.1159\/000355888","article-title":"Sepsis-induced potentiation of peritoneal macrophage migration is mitigated by programmed cell death receptor-1 gene deficiency","author":"Ayala","year":"2014","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.bcp.2026.118338_b0805","doi-asserted-by":"crossref","DOI":"10.1152\/ajpgi.00371.2015","article-title":"Contribution of programmed cell death receptor (PD)-1 to Kupffer cell dysfunction in murine polymicrobial sepsis","author":"Wang","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bcp.2026.118338_b0810","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2021.9831","article-title":"Programmed cell death-1\/programmed cell death-ligand 1 inhibitors exert antiapoptosis and antiinflammatory activity in lipopolysaccharide stimulated murine alveolar macrophages","author":"Jia","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bcp.2026.118338_b0815","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-025-03250-z","article-title":"Mesenchymal stem cell-derived extracellular vesicles alleviate autism by regulating microglial glucose metabolism reprogramming and neuroinflammation through PD-1\/PD-L1 interaction","author":"Qin","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bcp.2026.118338_b0820","article-title":"PD-1-positive tumor-associated macrophages define poor clinical outcomes in patients with muscle invasive bladder cancer through potential CD68\/PD-1 complex interactions","author":"Jiang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2026.118338_b0825","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-6629-6","article-title":"Increased PD-1-positive macrophages in the tissue of gastric cancer are closely associated with poor prognosis in gastric cancer patients","author":"Kono","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2026.118338_b0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2019.12.007","article-title":"Stromal PD-1+ tumor-associated macrophages predict poor prognosis in lung adenocarcinoma","author":"Chen","year":"2020","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bcp.2026.118338_b0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2023.02.005","article-title":"Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment","author":"Klement","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2026.118338_b0840","article-title":"Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy","author":"Liu","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118338_b0845","doi-asserted-by":"crossref","DOI":"10.1172\/JCI120803","article-title":"Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression","author":"Lin","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118338_b0850","article-title":"Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice","author":"Lau","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118338_b0855","doi-asserted-by":"crossref","DOI":"10.1172\/JCI96061","article-title":"PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression","author":"Tang","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118338_b0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.04.014","article-title":"Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses","author":"Lavin","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118338_b0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2023.07.026","article-title":"Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin","author":"Ruf","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118338_b0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2021.09.009","article-title":"Tumor and tumor-associated macrophage programmed death-ligand 1 expression is associated with adjuvant chemotherapy benefit in lung adenocarcinoma","author":"Gross","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bcp.2026.118338_b0875","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1718217115","article-title":"Role of PD-1 during effector CD8 T cell differentiation","author":"Ahn","year":"2018","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2026.118338_b0880","doi-asserted-by":"crossref","DOI":"10.1152\/ajpgi.00197.2019","article-title":"Hepatitis B virus-triggered PTEN\/\u03b2-catenin\/c-Myc signaling enhances PD-L1 expression to promote immune evasion","author":"Sun","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bcp.2026.118338_b0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145935","article-title":"Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression","author":"Xuan Hoan","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.bcp.2026.118338_b0890","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.832206","article-title":"CD8+ T-cell exhaustion phenotype in chronic hepatitis C virus infection is associated with epitope sequence variation","author":"Osuch","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0895","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2008.02.033","article-title":"Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization","author":"Nakamoto","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2026.118338_b0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104254","article-title":"Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function","author":"Brunet-Ratnasingham","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bcp.2026.118338_b0905","doi-asserted-by":"crossref","DOI":"10.1007\/s00011-021-01493-8","article-title":"Blockade of macrophage-associated programmed death 1 inhibits the pyroptosis signalling pathway in sepsis","author":"Fu","year":"2021","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bcp.2026.118338_b0910","article-title":"Alteration of macrophage immune phenotype in a murine sepsis model is associated with susceptibility to secondary fungal infection","author":"Vu","year":"2022","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0915","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1632902","article-title":"Immune checkpoint receptors tim-3 and PD-1 regulate monocyte and T lymphocyte function in septic patients","author":"Xia","year":"2018","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bcp.2026.118338_b0920","doi-asserted-by":"crossref","DOI":"10.1189\/jlb.4HI0616-255R","article-title":"Frontline science: defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1","author":"Patera","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2026.118338_b0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2016.04.008","article-title":"Maternal-derived hepatitis B virus e antigen alters macrophage function in offspring to drive viral persistence after vertical transmission","author":"Tian","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2026.118338_b0930","doi-asserted-by":"crossref","DOI":"10.1002\/hep.23173","article-title":"Chronically inflamed livers up-regulate expression of inhibitory B7 family members","author":"Kassel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2026.118338_b0935","doi-asserted-by":"crossref","DOI":"10.2174\/1874613601408010066","article-title":"Immune suppression by myeloid cells in HIV infection: new targets for immunotherapy","author":"Mehraj","year":"2014","journal-title":"Open AIDS J."},{"key":"10.1016\/j.bcp.2026.118338_b0940","article-title":"Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10","author":"Rodr\u00edguez-Garc\u00eda","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2026.118338_b0945","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00817-21","article-title":"Candida auris bloodstream infection induces upregulation of the PD-1\/PD-L1 immune checkpoint pathway in an immunocompetent mouse model","author":"Wurster","year":"2022","journal-title":"mSphere"},{"key":"10.1016\/j.bcp.2026.118338_b0950","article-title":"The role and mechanisms of PD-L1 in immune evasion during Talaromyces marneffei infection","author":"Wang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2026.118338_b0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101938","article-title":"Mitogen-activated protein kinase phosphatase-1 controls PD-L1 expression by regulating type I interferon during systemic Escherichia coli infection","author":"Barley","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118338_b0960","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiab274","article-title":"Anti-PD-L1 Therapy does not improve survival in a murine model of lethal staphylococcus aureus pneumonia","author":"Curran","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bcp.2026.118338_b0965","doi-asserted-by":"crossref","DOI":"10.1093\/intimm\/dxab044","article-title":"Helicobacter urease suppresses cytotoxic CD8+ T-cell responses through activating Myh9-dependent induction of PD-L1","author":"Wu","year":"2021","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b0970","article-title":"Increased CD86 but not CD80 and PD-L1 expression on liver CD68+ cells during chronic HBV infection","author":"Said","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.118338_b0975","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-024-01952-8","article-title":"Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders","author":"Song","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2026.118338_b0980","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2013.05.003","article-title":"Recent insights into the role of the PD-1\/PD-L1 pathway in immunological tolerance and autoimmunity","author":"Gianchecchi","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bcp.2026.118338_b0985","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121517","article-title":"Engineered PD-1\/TIGIT dual-activating cell-membrane nanoparticles with dexamethasone act synergistically to shape the effector T cell\/Treg balance and alleviate systemic lupus erythematosus","author":"Guo","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.bcp.2026.118338_b0990","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152582","article-title":"Immune checkpoint inhibitors and rheumatoid arthritis: All roads lead to PD-1?","author":"Cappelli","year":"2025","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.bcp.2026.118338_b0995","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.177.12.8844","article-title":"Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis","author":"Wan","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b1000","doi-asserted-by":"crossref","DOI":"10.1002\/art.27500","article-title":"The programmed death 1\/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis","author":"Raptopoulou","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2026.118338_b1005","doi-asserted-by":"crossref","DOI":"10.1002\/art.42749","article-title":"Programmed death ligand 1-expressing macrophages and their protective role in the joint during arthritis","author":"Wood","year":"2024","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bcp.2026.118338_b1010","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-019-1588-z","article-title":"Estrogen-induced compensatory mechanisms protect IL-10-deficient mice from developing EAE","author":"Seifert","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2026.118338_b1015","doi-asserted-by":"crossref","DOI":"10.1002\/art.41554","article-title":"Distinct expression of coinhibitory molecules on alveolar T cells in patients with rheumatoid arthritis-associated and idiopathic inflammatory myopathy-associated interstitial lung disease","author":"Nakazawa","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bcp.2026.118338_b1020","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2209856","article-title":"A phase 2 trial of peresolimab for adults with rheumatoid arthritis","author":"Tuttle","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118338_b1025","article-title":"The effect of combining PD-1 agonist and low-dose Interleukin-2 on treating systemic lupus erythematosus","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b1030","doi-asserted-by":"crossref","unstructured":"Wang K, Zhao J, Feng X, et al. PD-1\/PD-L1 governed cross-talk of exhausted CD8+ T and memory B cells in systemic lupus erythematosus. RMD Open. 2024; Published 2024 Jan 17. doi:10.1136\/rmdopen-2023-003503.","DOI":"10.1136\/rmdopen-2023-003503"},{"key":"10.1016\/j.bcp.2026.118338_b1035","doi-asserted-by":"crossref","DOI":"10.7150\/thno.107418","article-title":"PD-1 activation mitigates lupus nephritis by suppressing hyperactive and heterogeneous PD-1+CD8+ T cells","author":"Deng","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2026.118338_b1040","doi-asserted-by":"crossref","DOI":"10.1007\/s12264-021-00683-y","article-title":"Emerging role of PD-1 in the central nervous system and brain diseases","author":"Zhao","year":"2021","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.bcp.2026.118338_b1045","doi-asserted-by":"crossref","DOI":"10.1161\/STROKEAHA.111.613182","article-title":"Programmed death-1 pathway limits central nervous system inflammation and neurologic deficits in murine experimental stroke","author":"Ren","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.bcp.2026.118338_b1050","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2016.10.001","article-title":"Programmed death (PD)-1 attenuates macrophage activation and brain inflammation via regulation of fibrinogen-like protein 2 (Fgl-2) after intracerebral hemorrhage in mice","author":"Yuan","year":"2016","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bcp.2026.118338_b1055","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108662","article-title":"Microglial PD-1 stimulation by astrocytic PD-L1 suppresses neuroinflammation and Alzheimer's disease pathology","author":"Kummer","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2026.118338_b1060","doi-asserted-by":"crossref","DOI":"10.1038\/nm.4022","article-title":"PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease","author":"Baruch","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2026.118338_b1065","article-title":"Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy","author":"Chen","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118338_b1070","doi-asserted-by":"crossref","DOI":"10.1002\/glia.23260","article-title":"Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-\u03b2 burden in several amyloid transgenic mouse models","author":"Latta-Mahieu","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2026.118338_b1075","article-title":"Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model","author":"Lin","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bcp.2026.118338_b1080","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.15620","article-title":"Trained immunity in organ transplantation","author":"Ochando","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.bcp.2026.118338_b1085","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142909","article-title":"Overexpression of PD-1 on T cells promotes tolerance in cardiac transplantation via ICOS-dependent mechanisms","author":"Borges","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.bcp.2026.118338_b1090","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-6143.2009.02859.x","article-title":"PD-1\/B7-H1 interaction contribute to the spontaneous acceptance of mouse liver allograft","author":"Morita","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.bcp.2026.118338_b1095","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.174.6.3408","article-title":"Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo","author":"Sandner","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b1100","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.12803","article-title":"The role of macrophages in the development of human renal allograft fibrosis in the first year after transplantation","author":"Toki","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.bcp.2026.118338_b1105","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.13014","article-title":"Acute and chronic rejection: compartmentalization and kinetics of counterbalancing signals in cardiac transplants","author":"Kaul","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.bcp.2026.118338_b1110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajt.2023.07.023","article-title":"Delayed graft rejection in autoimmune islet transplantation via biomaterial immunotherapy","author":"Coronel","year":"2023","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.bcp.2026.118338_b1115","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.13808","article-title":"Graft-infiltrating macrophages adopt an M2 phenotype and are inhibited by purinergic receptor P2X7 antagonist in chronic rejection","author":"Wu","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.bcp.2026.118338_b1120","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.14543","article-title":"Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model","author":"Zhao","year":"2018","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.bcp.2026.118338_b1125","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103004","article-title":"Immune checkpoint blockers in solid organ transplant recipients and cancer: the INNOVATED cohort","author":"Remon","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.bcp.2026.118338_b1130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2019.07.005","article-title":"Immune checkpoint inhibitor therapy in solid organ transplant recipients: A patient-centered systematic review","author":"Fisher","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bcp.2026.118338_b1135","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2021.11.029","article-title":"Allorecognition and the spectrum of kidney transplant rejection","author":"Callemeyn","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2026.118338_b1140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25073671","article-title":"The PD-1\/PD-L1 axis in the biology of MASLD","author":"Pipitone","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118338_b1145","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-021-01384-6","article-title":"The role of programmed death-1 in type 1 diabetes","author":"Tucker","year":"2021","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.bcp.2026.118338_b1150","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5035261","article-title":"Unlike PD-L1, PD-1 is downregulated on partial immune cells in type 2 diabetes","author":"Sun","year":"2019","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.bcp.2026.118338_b1155","doi-asserted-by":"crossref","DOI":"10.1111\/cei.12603","article-title":"Low programmed cell death-1 (PD-1) expression in peripheral CD4(+) T cells in Japanese patients with autoimmune type 1 diabetes","author":"Fujisawa","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bcp.2026.118338_b1160","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221920","article-title":"Single-cell profiling reveals unique features of diabetogenic T cells in anti-PD-1-induced type 1 diabetes mice","author":"Collier","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2026.118338_b1165","doi-asserted-by":"crossref","DOI":"10.1007\/s12272-010-1115-3","article-title":"Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes","author":"Won","year":"2010","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bcp.2026.118338_b1170","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.15582","article-title":"PD-1 mRNA expression in peripheral blood mononuclear cells as a biomarker for different stages of primary gouty arthritis","author":"Su","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bcp.2026.118338_b1175","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15586","article-title":"Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease","author":"Pipitone","year":"2023","journal-title":"Liver Int."},{"key":"10.1016\/j.bcp.2026.118338_b1180","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2021.10.003","article-title":"Mechanisms of immune checkpoint inhibitor-mediated liver injury","author":"Shojaie","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.118338_b1185","doi-asserted-by":"crossref","DOI":"10.1111\/liv.14336","article-title":"Tolerogenic properties of liver macrophages in non-alcoholic steatohepatitis","author":"Orci","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.bcp.2026.118338_b1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2018.10.091","article-title":"PD-1 is involved in the dysregulation of type 2 innate lymphoid cells in a murine model of obesity","author":"Oldenhove","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2026.118338_b1195","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.00569","article-title":"Role of the PD-1\/PD-L1 dyad in the maintenance of pancreatic immune tolerance for prevention of Type 1 diabetes","author":"Falcone","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bcp.2026.118338_b1200","article-title":"Engineered cytokine-primed extracellular vesicles with High PD-L1 expression ameliorate type 1 diabetes","author":"Wang","year":"2023","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.bcp.2026.118338_b1205","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cmet.2025.11.009","article-title":"Macrophage PD-1 regulates energy expenditure and metabolic dysfunction under immune checkpoint blockade","volume":"38","author":"Wu","year":"2026","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2026.118338_b1210","doi-asserted-by":"crossref","unstructured":"Leitner J, Schindler H, Gumpelmair S, Hafner C, Steinberger P. Evaluation of small molecule PD-1\/PD-L1 inhibitors in a T cell reporter system. Biochem Pharmacol. Published online March 7, 2026. doi:10.1016\/j.bcp.2026.117871.","DOI":"10.1016\/j.bcp.2026.117871"},{"key":"10.1016\/j.bcp.2026.118338_b1215","doi-asserted-by":"crossref","unstructured":"Slota A, Golebiowska-Mendroch K, Kocik-Krol J, et al. Characterization of Clinically Evaluated Small-Molecule Inhibitors of PD-L1 for Immunotherapy. ACS Med Chem Lett. 2025;16(7):1359-1364. Published 2025 Jun 9. doi:10.1021\/acsmedchemlett.5c00245.","DOI":"10.1021\/acsmedchemlett.5c00245"},{"issue":"6","key":"10.1016\/j.bcp.2026.118338_b1220","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1158\/2159-8290.CD-21-1156","article-title":"Characterization of INCB086550: a potent and novel small-molecule PD-L1 inhibitor","volume":"12","author":"Koblish","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bcp.2026.118338_b1225","doi-asserted-by":"crossref","unstructured":"Chen FF, Li Z, Ma D, Yu Q. Small-molecule PD-L1 inhibitor BMS1166 abrogates the function of PD-L1 by blocking its ER export. Oncoimmunology. 2020;9(1):1831153. Published 2020 Oct 14. doi:10.1080\/2162402X.2020.1831153.","DOI":"10.1080\/2162402X.2020.1831153"},{"key":"10.1016\/j.bcp.2026.118338_b1230","doi-asserted-by":"crossref","unstructured":"Cao H, Xiang Y, Zhang S, et al. PD-L1 regulates inflammatory programs of macrophages from human pluripotent stem cells. Life Sci Alliance. 2023;7(2):e202302461. Published 2023 Nov 10. doi:10.26508\/lsa.202302461.","DOI":"10.26508\/lsa.202302461"},{"key":"10.1016\/j.bcp.2026.118338_b1235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118238","article-title":"Advances in cancer immunotherapy using small-molecular inhibitors targeting the PD-1\/PD-L1 interaction","volume":"127","author":"Zhang","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118338_b1240","doi-asserted-by":"crossref","unstructured":"Wang YH, Li AG, Wang HY, Tu YS. Repression of JAK2-STAT1 and PD-L1 by CEP-33779 ameliorates the LPS-induced decline in phagocytic activity of alveolar macrophages and mitigates lung injury in mice. Front Immunol. 2024;15:1472425. Published 2024 Nov 26. doi:10.3389\/fimmu.2024.1472425.","DOI":"10.3389\/fimmu.2024.1472425"},{"key":"10.1016\/j.bcp.2026.118338_b1245","doi-asserted-by":"crossref","unstructured":"Kim TW, Kim Y, Keum H, Jung W, Kang M, Jon S. Combination of a STAT3 inhibitor with anti-PD-1 immunotherapy is an effective treatment regimen for a vemurafenib-resistant melanoma. Mol Ther Oncolytics. 2022;26:1-14. Published 2022 Jun 6. doi:10.1016\/j.omto.2022.06.001.","DOI":"10.1016\/j.omto.2022.06.001"},{"key":"10.1016\/j.bcp.2026.118338_b1250","doi-asserted-by":"crossref","unstructured":"Han Z, Wu X, Qin H, et al. Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma. JCI Insight. 2023;8(13):e163518. Published 2023 Jul 10. doi:10.1172\/jci.insight.163518.","DOI":"10.1172\/jci.insight.163518"},{"key":"10.1016\/j.bcp.2026.118338_b1255","doi-asserted-by":"crossref","unstructured":"L\u00f3pez Moreno SF, Lenz SA, Casso-Chapa B, et al. SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular Risk. Antioxidants (Basel). 2025;14(12):1388. Published 2025 Nov 21. doi:10.3390\/antiox14121388.","DOI":"10.3390\/antiox14121388"},{"key":"10.1016\/j.bcp.2026.118338_b1260","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107096","article-title":"Allosteric inhibitor of SHP2 enhances macrophage endocytosis and bacteria elimination by increasing caveolae activation and protects against bacterial sepsis","volume":"201","author":"Li","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118338_b1265","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1084\/jem.20112741","article-title":"Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2","volume":"209","author":"Yokosuka","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2026.118338_b1270","doi-asserted-by":"crossref","unstructured":"Ahmari N, Choi K, Wu J, et al. Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromas. Life Sci Alliance. 2025;8(12):e202503359. Published 2025 Sep 24. doi:10.26508\/lsa.202503359.","DOI":"10.26508\/lsa.202503359"},{"issue":"13","key":"10.1016\/j.bcp.2026.118338_b1275","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1158\/0008-5472.CAN-19-3038","article-title":"Allosteric inhibition of SHP2 Stimulates antitumor immunity by transforming the immunosuppressive environment","volume":"80","author":"Quintana","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118338_b1280","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fimmu.2020.00740","article-title":"Fc\u03b3R binding and ADCC activity of human IgG allotypes","volume":"11","author":"de Taeye","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118338_b1285","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00262-022-03365-4","article-title":"Exploring the potential of combining IL-2-activated NK cells with an anti-PDL1 monoclonal antibody to target multiple myeloma-associated macrophages","volume":"72","author":"Ehlers","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.bcp.2026.118338_b1290","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.apsb.2022.08.006","article-title":"Anti-PD-L1 antibody enhances curative effect of cryoablation via antibody-dependent cell-mediated cytotoxicity mediating PD-L1highCD11b+ cells elimination in hepatocellular carcinoma","volume":"13","author":"Tan","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"Suppl 2","key":"10.1016\/j.bcp.2026.118338_b1295","first-page":"A1121","article-title":"Discovery of a PD-L1-directed ISAC optimized for the activation of PD-L1-expressing myeloid cells to drive potent antitumor immune responses","volume":"13","author":"Ho","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"7","key":"10.1016\/j.bcp.2026.118338_b1300","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1016\/j.apsb.2025.05.005","article-title":"Non-blocking anti-PD-L1 nanobody conjugated to TLR7 agonist mediates macrophage\/NK cell-associated antitumor effects","volume":"15","author":"Hu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.118338_b1305","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217475","article-title":"FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity","volume":"612","author":"Wei","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2026.118338_b1310","doi-asserted-by":"crossref","unstructured":"Chen F, Bai G, Liu Q, et al. Integrated multi-omics identifies a CD54+ iCAF-ITGAL+ macrophage niche driving immunosuppression via CXCL8-PDL1 axis in cervical cancer. Mol Cancer. 2025;24(1):262. Published 2025 Oct 21. doi:10.1186\/s12943-025-02471-y.","DOI":"10.1186\/s12943-025-02471-y"},{"issue":"1","key":"10.1016\/j.bcp.2026.118338_b1315","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12943-023-01731-z","article-title":"Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Pei","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.118338_b1320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175087","article-title":"Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs); where do they stand in tumorigenesis and how they can change the face of cancer therapy?","volume":"928","author":"Tajaldini","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118338_b1325","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2025.101234","article-title":"PD-L1(+) tumor-associated macrophages induce CD8(+) T Cell exhaustion in hepatocellular carcinoma","volume":"69","author":"Nosaka","year":"2025","journal-title":"Neoplasia"},{"issue":"7","key":"10.1016\/j.bcp.2026.118338_b1330","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1007\/s00210-025-04884-4","article-title":"Innovative immunotherapy approaches: harnessing synergy of dual checkpoint blockade in oncology","volume":"399","author":"Shaik","year":"2026","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118338_b1335","doi-asserted-by":"crossref","unstructured":"Jiang X, Wang J, Lin L, et al. Macrophages promote pre-metastatic niche formation of breast cancer through aryl hydrocarbon receptor activity. Signal Transduct Target Ther. 2024;9(1):352. Published 2024 Dec 18. doi:10.1038\/s41392-024-02042-5.","DOI":"10.1038\/s41392-024-02042-5"},{"issue":"1","key":"10.1016\/j.bcp.2026.118338_b1340","article-title":"Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells","volume":"5","author":"Sprooten","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bcp.2026.118338_b1345","doi-asserted-by":"crossref","unstructured":"Savardekar H, Stiff A, Liu A, et al. BRD4 inhibition leads to MDSC apoptosis and enhances checkpoint blockade therapy. J Clin Invest. 2025;135(19):e181975. Published 2025 Aug 5. doi:10.1172\/JCI181975.","DOI":"10.1172\/JCI181975"},{"issue":"3","key":"10.1016\/j.bcp.2026.118338_b1350","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11060-024-04689-0","article-title":"Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc\/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy","volume":"168","author":"Sun","year":"2024","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.bcp.2026.118338_b1355","doi-asserted-by":"crossref","unstructured":"Hu X, Huang J, Li Z, et al. Lactate promotes microglial scar formation and facilitates locomotor function recovery by enhancing histone H4 lysine 12 lactylation after spinal cord injury. J Neuroinflammation. 2024;21(1):193. Published 2024 Aug 3. doi:10.1186\/s12974-024-03186-5.","DOI":"10.1186\/s12974-024-03186-5"},{"key":"10.1016\/j.bcp.2026.118338_b1360","doi-asserted-by":"crossref","unstructured":"Zhou Z, Zhang X, Zhu S, et al. Crizotinib: A Novel Strategy to Reverse Immunosuppression in Melanoma by Targeting Lactate Transport. MedComm (2020). 2025;6(8):e70286. Published 2025 Jul 21. doi:10.1002\/mco2.70286.","DOI":"10.1002\/mco2.70286"},{"key":"10.1016\/j.bcp.2026.118338_b1365","doi-asserted-by":"crossref","unstructured":"Tian Z, Zhang K, Sheng S, Kan C, Han F, Sun X. The Role of Lactate Metabolism in Tumors: From Metabolic Byproduct to Signaling Molecule. Am J Clin Oncol. Published online November 26, 2025. doi:10.1097\/COC.0000000000001276.","DOI":"10.1097\/COC.0000000000001276"},{"key":"10.1016\/j.bcp.2026.118338_b1370","doi-asserted-by":"crossref","unstructured":"Marletta S, Fusco N, Munari E, et al. Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems. J Pers Med. 2022;12(7):1073. Published 2022 Jun 29. doi:10.3390\/jpm12071073.","DOI":"10.3390\/jpm12071073"},{"key":"10.1016\/j.bcp.2026.118338_b1375","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104980","article-title":"Predictive models for immune checkpoint inhibitor response in cancer: A review of current approaches and future directions","volume":"216","author":"Oisakede","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"11","key":"10.1016\/j.bcp.2026.118338_b1380","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1038\/s41416-023-02238-6","article-title":"Spatially resolved multimarker evaluation of CD274 (PD-L1)\/PDCD1 (PD-1) immune checkpoint expression and macrophage polarisation in colorectal cancer","volume":"128","author":"Elomaa","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.bcp.2026.118338_b1385","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007585","article-title":"PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma","volume":"11","author":"Homicsko","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bcp.2026.118338_b1390","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1138054","article-title":"Spatial distribution of tumor-infiltrating T cells indicated immune response status under chemoradiotherapy plus PD-1 blockade in esophageal cancer","volume":"14","author":"Yan","year":"2023","journal-title":"Front. Immunol."},{"issue":"12_Suppl","key":"10.1016\/j.bcp.2026.118338_b1395","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1158\/1538-7445.AM2022-1235","article-title":"Abstract 1235: Presence of TLS and combined high densities of PD-L1+ macrophages & CD8+ T cells predict long-term overall survival for patients with advanced NSCLC treated with durvalumab","volume":"82","author":"Meinecke","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118338_b1400","doi-asserted-by":"crossref","unstructured":"Botti G, Scognamiglio G, Cantile M. PD-L1 Immunohistochemical Detection in Tumor Cells and Tumor Microenvironment: Main Considerations on the Use of Tissue Micro Arrays. Int J Mol Sci. 2016;17(7):1046. Published 2016 Jun 30. doi:10.3390\/ijms17071046.","DOI":"10.3390\/ijms17071046"},{"issue":"1","key":"10.1016\/j.bcp.2026.118338_b1405","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12967-025-06186-y","article-title":"Spatial interaction mapping of PD-1\/PD-L1 in head and neck cancer reveals the role of macrophage-tumour barriers associated with immunotherapy response","volume":"23","author":"Naei","year":"2025","journal-title":"J. Transl. Med."},{"issue":"7","key":"10.1016\/j.bcp.2026.118338_b1410","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/jclinpath-2021-207448","article-title":"Validation of multiplex immunofluorescence and digital image analysis for programmed death-ligand 1 expression and immune cell assessment in non-small cell lung cancer: comparison with conventional immunohistochemistry","volume":"75","author":"Wu","year":"2022","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bcp.2026.118338_b1415","doi-asserted-by":"crossref","unstructured":"Zhai J, Tamegnon A, Jiang M, Pandurengan RK, Parra ER. Immune profiling of mouse lung adenocarcinoma paraffin tissues using multiplex immunofluorescence panel: a pilot study. Lab Anim Res. 2024;40(1):24. Published 2024 Jun 14. doi:10.1186\/s42826-024-00210-w.","DOI":"10.1186\/s42826-024-00210-w"},{"issue":"2","key":"10.1016\/j.bcp.2026.118338_b1420","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1158\/0008-5472.CAN-24-0954","article-title":"ACE2 enhances sensitivity to PD-L1 blockade by inhibiting macrophage-induced immunosuppression and angiogenesis","volume":"85","author":"Xie","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118338_b1425","doi-asserted-by":"crossref","unstructured":"Ohkuma R, Fujimoto Y, Ieguchi K, et al. Monocyte subsets associated with the efficacy of anti-PD-1 antibody monotherapy. Oncol Lett. 2023;26(3):381. Published 2023 Jul 20. doi:10.3892\/ol.2023.13967.","DOI":"10.3892\/ol.2023.13967"},{"key":"10.1016\/j.bcp.2026.118338_b1430","doi-asserted-by":"crossref","unstructured":"Wang PH, Wu MF, Hsu CY, et al. The Dynamic Change of Immune Checkpoints and CD14+ Monocytes in Latent Tuberculosis Infection. Biomedicines. 2021;9(10):1479. Published 2021 Oct 15. doi:10.3390\/biomedicines9101479.","DOI":"10.3390\/biomedicines9101479"},{"issue":"4","key":"10.1016\/j.bcp.2026.118338_b1435","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.3892\/etm.2016.3611","article-title":"Increased soluble and membrane-bound PD-L1 contributes to immune regulation and disease progression in patients with tuberculous pleural effusion","volume":"12","author":"Pan","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"10","key":"10.1016\/j.bcp.2026.118338_b1440","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99281","article-title":"Cytometry TOF identifies alveolar macrophage subtypes in acute respiratory distress syndrome","volume":"3","author":"Morrell","year":"2018","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.bcp.2026.118338_b1445","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1038\/s41598-020-61489-y","article-title":"Characterization of pulmonary immune responses to hyperoxia by high-dimensional mass cytometry analyses","volume":"10","author":"Hanidziar","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118338_b1450","doi-asserted-by":"crossref","unstructured":"Vall\u00e9e A, Drezet A, Arutkin M. Pan-cancer convergence of tumour-immune microenvironment motifs revealed by CyTOF and imaging mass cytometry. Front Immunol. 2025;16:1672312. Published 2025 Oct 6. doi:10.3389\/fimmu.2025.1672312.","DOI":"10.3389\/fimmu.2025.1672312"},{"issue":"14","key":"10.1016\/j.bcp.2026.118338_b1455","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1158\/0008-5472.CAN-21-3506","article-title":"Therapeutic Targeting of macrophage plasticity remodels the tumor-immune microenvironment","volume":"82","author":"Jang","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118338_b1460","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/978-1-4939-9773-2_25","article-title":"High-plex spatially resolved RNA and protein detection using digital spatial profiling: a technology designed for immuno-oncology biomarker discovery and translational research","volume":"2055","author":"Beechem","year":"2020","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/j.bcp.2026.118338_b1465","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/s41588-025-02351-7","article-title":"Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer","volume":"57","author":"Aung","year":"2025","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2026.118338_b1470","article-title":"Mutual regulation of PD-L1 immunosuppression between tumor-associated macrophages and tumor cells: a critical role for exosomes","author":"Wang","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bcp.2026.118338_b1475","article-title":"Profiling phagosome proteins identifies PD-L1 as a fungal-binding receptor","author":"Li","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118338_b1480","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216883","article-title":"d-mannose targets PD-1 to lysosomal degradation and enhances T cell-mediated anti-tumor immunity","author":"Dong","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2026.118338_b1485","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M117.793885","article-title":"Hormonal vitamin D up-regulates tissue-specific PD-L1 and PD-L2 surface glycoprotein expression in humans but not mice","author":"Dimitrov","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118338_b1490","first-page":"2024","article-title":"Unraveling the role of M1 macrophage and CXCL9 in predicting immune checkpoint inhibitor efficacy through multicohort analysis and single-cell RNA sequencing","author":"Yu","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.bcp.2026.118338_b1495","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat1500","article-title":"Human tumor-associated monocytes\/macrophages and their regulation of T cell responses in early-stage lung cancer","author":"Singhal","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2026.118338_b1500","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-019-0374-x","article-title":"Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy","author":"Wang","year":"2019","journal-title":"Nat. Med."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:15:30Z","timestamp":1788812130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226006775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":300,"alternative-id":["S0006295226006775"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118338","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-1+\/PD-L1+macrophages across diseases: a translational continuum from biomarkers to immunotherapeutic targets","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118338"}}